Write in a clean editor, then format for iLiver in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
iLiver is a peer-reviewed journal published by Elsevier, covering Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, iLiver 12 (2023) 45–58.
Formats any DOI in iLiver style. No sign-up. |
| Publishes research in | Hepatocellular Carcinoma Treatment and Prognosis Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Organ Transplantation Techniques and Outcomes Cholangiocarcinoma and Gallbladder Cancer Studies |
| ISSN | 2772-9478 |
| Citation impact (2-yr) | 2.38 |
| h-index | 11 |
| i10-index | 18 |
| Total citations | 590 |
| Open access | Yes |
| Top institutions publishing here | Chinese PLA General Hospital |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Hepatocellular carcinoma (HCC) is a prevalent malignancy worldwide, ranking as the sixth most common malignancy and the third leading cause of cancer-related mortality. Late diagnosis, limited management options, and its complex etiology contribute to the poor prognosis and high mortality rates. Recent advances in understanding the molecular mechanisms of HCC and innovations in high-throughput sequencing…
The liver is a pivotal organ that maintains internal homeostasis and actively participates in multiple physiological processes. Liver tissue engineering (LTE), by which in vitro biomimetic liver models are constructed, serves as a platform for disease research, drug screening, and cell replacement therapies. 3D bioprinting is used in tissue engineering to create microenvironments that closely…
Numerous recent studies have shown that myeloid-derived suppressor cells (MDSCs), a strongly heterogeneous population of immunosuppressive cells, are dysregulated in the presence of many cancers. MDSCs present different phenotypes and play prominent roles in the tumor microenvironment. To date, gene therapies targeting MDSCs are the most innovative and flexible methods to specifically modify the tumor…
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a widespread and potentially severe liver condition characterized by abnormal fat accumulation in the liver unrelated to alcohol consumption. According to the World Health Organization, MASLD is the most prevalent liver disease globally, it affects approximately 25% of the world’s population, nearly two billion individuals. This staggering prevalence…
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. With the development of systemic therapies, several studies are currently underway, especially those related to the use of programmed death-1/programmed cell death-ligand 1 (PD-1/PD-L1) immunotherapy. Moreover, studies on transarterial chemoembolization (TACE) and PD-1/PD-L1 immunotherapy have demonstrated some interesting outcomes. This article reviewed the current…
